| 000 | 01923cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030337.0 | ||
| 008 | 110117s2010 ua h f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.04.Ph.D.2010.Af.S | ||
| 100 | 0 | _aAfaf Ali Atia Elmalah | |
| 245 | 1 | 0 |
_aSynthesis of certain fused thienopyridine derivatives of expected activity against alzheimer's disease / _cAfaf Ali Atia Elmalah ; Supervised Mohga Mohamed Badran , Maha Abdelhakeem , Suzan Mohamed Abuelmaaty |
| 246 | 1 | 5 | _aتشييد بعض مركبات الثاينوبيريدين الملتحمة ذات نشاط متوقع ضد مرض الالزهيمر |
| 260 |
_aCairo : _bAfaf Ali Atia Elmalah , _c2010 |
||
| 300 |
_a120P. : _bfacsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Organic Chemistry | ||
| 520 | _aA survey covering the methods used for the synthesis of thienopyridine derivatives in addition to their reactions is illustrated . Abrief outline on their medical importance is also given . This thesis involves the preparation of the starting compounds 2- amino - 3- cyanothiophene derivatives {u2161}a-c (scheme 1) . cyclodehydration reaction between the aminocyanothiophenes and the appropriate cyclanone was achieved by using two methods to obtain thienopyridine derivatives {u2162}a-c, IVa-c, {u2164}a-c, {u2165}I, {u2167} and IX(scheme 2- 4) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAlzheimer's disease | |
| 653 | 4 | _aTacrine | |
| 653 | 4 | _aThienopyridine derivatives | |
| 700 | 0 |
_aMaha Abdelhakeem , _eSupervisor |
|
| 700 | 0 |
_aMohga Mohamed Badran , _eSupervisor |
|
| 700 | 0 |
_aSuzan Mohamed Abuelmaaty , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c32720 _d32720 |
||